SCHEMBL3774241

SCHEMBL3774241

CCn1cc[n+](C(C)(C)C)c1

nearest known ligand 0.36

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
FDPS P14324 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3767086 0.83 MEN1 (0.39) FDPS
SCHEMBL424311 0.83 FDPS (0.35) FDPS
Iodide SCHEMBL4426706 0.82
SCHEMBL25803478 0.80 FDPS (0.30) FDPS
SCHEMBL3762952 0.79 MEN1 (0.49) FDPS
SCHEMBL17131176 0.78 MEN1 (0.56) FDPS
SCHEMBL372636 0.77 FDPS (0.33) FDPS
SCHEMBL424420 0.77 FDPS (0.33) FDPS
SCHEMBL17706445 0.74 MEN1 (0.37)
SCHEMBL372388 0.74 FDPS (0.33) FDPS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12291506-B2 Method for producing amidate compound, and amidate compound KOEI CHEMICAL COMPANY, LIMITED (JP) 2025-05-06 US disclosed
US-20240219836-A1 Conductive Polymer Composition, Coated Product, And Patterning Process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2024-07-04 US disclosed
US-11996557-B2 Direct regeneration of lithium ion cathodes by ionothermal relithiation UT-BATTELLE, LLC (US) 2024-05-28 US disclosed
US-11795583-B2 Plasticized melt spinning process using ionic liquids for production of polyacrylonitrile fibers UT-BATTELLE, LLC (US) 2023-10-24 US disclosed
US-11696912-B2 Charged ion channel blockers and methods for use Nocion Therapeutics, Inc. (US) 2023-07-11 US disclosed
US-20220376240-A1 DIRECT REGENERATION OF LITHIUM ION CATHODES BY IONOTHERMAL RELITHIATION U. S. DEPARTMENT OF ENERGY 2022-11-24 US disclosed
US-20220235493-A1 PLASTICIZED MELT SPINNING PROCESS USING IONIC LIQUIDS FOR PRODUCTION OF POLYACRYLONITRILE FIBERS UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION 2022-07-28 US disclosed
US-20220048864-A1 METHOD FOR PRODUCING AMIDATE COMPOUND, AND AMIDATE COMPOUND KOEI CHEMICAL COMPANY, LIMITED (JP) 2022-02-17 US disclosed
US-11251433-B2 Nitrogen-sulfur-carbon nanocomposites and their application as cathode materials in lithium-sulfur batteries UT-BATTELLE, LLC (US) 2022-02-15 US disclosed
US-11186893-B2 Rare earth amide compositions UT-BATTELLE, LLC (US) 2021-11-30 US disclosed
US-9233339-B2 Ionic liquid-functionalized mesoporous sorbents and their use in the capture of polluting gases UT-BATTELLE, LLC (US) 2016-01-12 US disclosed
US-8865094-B2 Methods for separating medical isotopes using ionic liquids UT-BATTELLE, LLC (US) 2014-10-21 US disclosed
WO-2014081793-A1 NITROGEN-SULFUR-CARBON NANOCOMPOSITES AND THEIR APPLICATION AS CATHODE MATERIALS IN LITHIUM-SULFUR BATTERIES UT-BATTELLE, LLC (US) 2014-05-30 WO disclosed
US-20140141328-A1 NITROGEN-SULFUR-CARBON NANOCOMPOSITES AND THEIR APPLICATION AS CATHODE MATERIALS IN LITHIUM-SULFUR BATTERIES UT-BATTELLE, LLC (US) 2014-05-22 US disclosed
US-20140113202-A1 ELECTROLYTE COMPOSITIONS FOR LITHIUM ION BATTERIES UT-BATTELLE, LLC (US) 2014-04-24 US disclosed
US-20140072485-A1 METHODS FOR SEPARATING MEDICAL ISOTOPES USING IONIC LIQUIDS UT-BATTELLE, LLC (US) 2014-03-13 US disclosed
US-8585886-B2 Method for synthesis of titanium dioxide nanotubes using ionic liquids UT-BATTELLE, LLC (US) 2013-11-19 US disclosed
US-20130280151-A1 IONIC LIQUID-FUNCTIONALIZED MESOPOROUS SORBENTS AND THEIR USE IN THE CAPTURE OF POLLUTING GASES U.S. DEPARTMENT OF ENERGY 2013-10-24 US disclosed
US-20120175266-A1 METHOD FOR SYNTHESIS OF TITANIUM DIOXIDE NANOTUBES USING IONIC LIQUIDS UT-BATTELLE, LLC (US) 2012-07-12 US disclosed
US-20100311615-A1 METHOD FOR SYNTHESIS OF TITANIUM DIOXIDE NANOTUBES USING IONIC LIQUIDS UT-BATTELLE, LLC (US) 2010-12-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12291506-B2 Method for producing amidate compound, and amidate compound NAAA, NIT2, PAM FDPS 299/4885
US-11696912-B2 Charged ion channel blockers and methods for use TRPV1, ASIC1, TRPA1 FDPS 2654/4885
US-20220048864-A1 METHOD FOR PRODUCING AMIDATE COMPOUND, AND AMIDATE COMPOUND NAAA, NIT2, PAM FDPS 299/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.